Table 1.
Variable | N | % |
---|---|---|
Age (median, IQR) | 53 (43–60) | |
19–30 | 160 | 4.5 |
31–40 | 568 | 15.8 |
41–50 | 782 | 21.8 |
51–60 | 1242 | 34.7 |
61–70 | 704 | 19.6 |
71–80 | 118 | 3.3 |
81 + | 10 | 0.2 |
Gender | ||
Cisgender male | 2300 | 64.2 |
Cisgender female | 1189 | 33.2 |
Transgender female (assigned male at birth) | 88 | 2.5 |
Transgender male (assigned female at birth) | 7 | 0.2 |
Unknown | 0 | 0.0 |
Race/ethnicity | ||
Non-Hispanic black | 2904 | 81.0 |
Non-Hispanic white | 348 | 9.7 |
Hispanic | 203 | 5.7 |
Other/unknown | 129 | 2.6 |
Unstably housed/homeless | 400 | 11.2 |
Unemployed/disabled | 1380 | 38.5 |
Recent CD4 count (last year only)a (median, IQR) | 643 (445–883) | |
Recent HIV viral load (last year only)a, copies/mL (median, IQR) | UD (UD-30) | |
Recent HIV viral load > 200 copies/mL (last year only)a | 308 | 8.6 |
Not on ART | 159 | 4.44 |
Ever smoker | 2108 | 58.8 |
Substance use disorder | 520 | 14.5 |
Chronic kidney disease/ESRD/hemodialysis | 428 | 11.9 |
Liver disease | 237 | 6.6 |
Cancer | 318 | 8.9 |
Hypertensiona | 2115 | 59.0 |
Diabetesa | 642 | 17.9 |
BMI 30 + (weight last year only)a kg/m2 | 995 | 27.8 |
BMI 40 + (weight last year only)a kg/m2 | 228 | 6.4 |
Cardiovascular disease | 337 | 9.4 |
Respiratory disease | 686 | 19.1 |
Asthma | 599 | 16.7 |
History of transplant | 0 | 0.0 |
Autoimmune/rheumatologic disease | 97 | 2.7 |
Hemoglobin disorder | 7 | 0.2 |
Dementia | 26 | 0.7 |
Risk for severe COVID-19 | ||
Low risk | 283 | 7.9 |
Increased risk | 2090 | 58.3 |
High risk | 1211 | 33.8 |
ESRD end stage renal disease, ART antiretroviral therapy, BMI body mass index, UD undetectable
aDue to missing values for clinical/laboratory results in the last year (Jul 2018–Jun 2019), not all participants could be evaluated for all conditions: BMI (n = 3133 with weight in last year and height ever); blood pressure (n = 3,198); glucose (n = 3158); HbA1c (n = 800), CD4 count (n = 2848), HIV viral load (n = 2822)